Montalban; Antonio Garrido

Patent Applications and Registrations

Patent applications and USPTO patent grants for Montalban; Antonio Garrido.The latest application filed is for "processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[b]indol-3-yl)acetic acid and salts thereof".

Company Profile

9.20.27

Montalban; Antonio Garrido - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20220259627 - Montalban; Antonio Garrido ; et al.	2022-08-18
Cannabinoid Receptor Modulators App 20220241274 - Thatte; Jayant ; et al.	2022-08-04
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20220002244 - Blackburn; Anthony C. ; et al.	2022-01-06
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20210380560 - Blackburn; Anthony C. ; et al.	2021-12-09
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[B]indol-3-yl)acetic acid and salts thereof Grant 11,149,292 - Montalban , et al. October 19, 2	2021-10-19
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P.sub.1 receptor-associated disorders Grant 11,091,435 - Blackburn , et al. August 17, 2	2021-08-17
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 10,981,895 - Blackburn , et al. April 20, 2	2021-04-20
Cannabinoid Receptor Modulators App 20210060040 - Thatte; Jayant ; et al.	2021-03-04
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20200361869 - Blackburn; Anthony C. ; et al.	2020-11-19
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders Grant 10,676,435 - Blackburn , et al.	2020-06-09
Cannabinoid receptor modulators Grant 10,632,134 - Thatte , et al.	2020-04-28
Cannabinoid Receptor Modulators App 20200069681 - Thatte; Jayant ; et al.	2020-03-05
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3- App 20190330153 - Blackburn; Anthony C. ; et al.	2019-10-31
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20190308952 - Blackburn; Anthony C. ; et al.	2019-10-10
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders Grant 10,301,262 - Blackburn , et al.	2019-05-28
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 10,183,930 - Blackburn , et al. Ja	2019-01-22
Cannabinoid Receptor Modulators App 20180280386 - Thatte; Jayant ; et al.	2018-10-04
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders App 20180186738 - Blackburn; Anthony C. ; et al.	2018-07-05
Cannabinoid receptor modulators Grant 9,867,822 - Thatte , et al. January 16, 2	2018-01-16
Cannabinoid Receptor Modulators App 20170304327 - Thatte; Jayant ; et al.	2017-10-26
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20170159088 - Montalban; Antonio Garrido ; et al.	2017-06-08
Cannabinoid Receptor Modulators App 20170143704 - Thatte; Jayant ; et al.	2017-05-25
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20170144993 - Blackburn; Anthony C. ; et al.	2017-05-25
Cannabinoid receptor modulators Grant 9,597,340 - Thatte , et al. March 21, 2	2017-03-21
Cannabinoid receptor modulators Grant 9,492,447 - Thatte , et al. November 15, 2	2016-11-15
Crystalline forms and processes for the preparation of cannabinoid receptor modulators Grant 9,458,136 - Blackburn , et al. October 4, 2	2016-10-04
Cannabinoid Receptor Modulators App 20160271127 - Thatte; Jayant ; et al.	2016-09-22
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocy- clopenta[B]indol-3-yl)acetic acid and salts thereof Grant 9,447,041 - Montalban , et al. September 20, 2	2016-09-20
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20160016904 - Montalban; Antonio Garrido ; et al.	2016-01-21
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocy- clopenta[B]indol-3-yl)acetic acid and salts thereof Grant 9,175,320 - Montalban , et al. November 3, 2	2015-11-03
Cannabinoid Receptor Modulators App 20150126477 - Thatte; Jayant ; et al.	2015-05-07
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20140357690 - Montalban; Antonio Garrido ; et al.	2014-12-04
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclopenta[b]indol-3-yl)acetic acid and salts thereof Grant 8,853,419 - Montalban , et al. October 7, 2	2014-10-07
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators App 20140135345 - Blackburn; Anthony C. ; et al.	2014-05-15
Processes For The Preparation Of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- Yclopenta[b]indol-3-yl)acetic Acid And Salts Thereof App 20120295947 - Montalban; Antonio Garrido ; et al.	2012-11-22
Cytokine inhibitors Grant 7,919,617 - Boman , et al. April 5, 2	2011-04-05
Cytokine inhibitors Grant 7,897,599 - Boman , et al. March 1, 2	2011-03-01
Alpha-ketoamides And Derivatives Thereof App 20100273797 - Boman; Erik ; et al.	2010-10-28
Alpha-ketoamides and derivatives thereof Grant 7,749,999 - Boman , et al. July 6, 2	2010-07-06
Cytokine Inhibitors App 20100093734 - Boman; Erik ; et al.	2010-04-15
Cytokine Inhibitors App 20100093735 - Boman; Erik ; et al.	2010-04-15
Cytokine inhibitors App 20050107399 - Boman, Erik ; et al.	2005-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.